Rebif Rebidose Injection, Solution
Product Images NDC 44087-3344

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Rebif Rebidose (NDC 44087-3344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rebif 01)

The text appears to be a graph that shows the proportion of patients who had progression over a certain number of years for a placebo group and two treatment groups (Rebif 44). The graph shows that both Rebif 44 treatment groups had a statistically significant lower proportion of patients with progression compared to the placebo group. The lower dose of Rebif 44 had a higher p-value (0.04) compared to the higher dose (0.01).*

FDA Label Image

Firgure A (Rebif 02)

FDA Label Image

Firgure B (Rebif 03)

The text is not-available.*

FDA Label Image

Firgure C (Rebif 04)

FDA Label Image

Firgure D (Rebif 05)

FDA Label Image

Firgure E (Rebif 06)

FDA Label Image

Firgure F (Rebif 07)

FDA Label Image

Image (Rebif 07a)

FDA Label Image

Warnings (Rebif 07b)

FDA Label Image

Image (Rebif 07c)

The text describes the components of an injector, including the injector button and body, the dose label area, the syringe plunger, a transparent syringe housing, and a needle cap that contains a needle shield. This information may be helpful for understanding or troubleshooting issues with the injector.*

FDA Label Image

Image (Rebif 07d)

FDA Label Image

Image (Rebif 07e)

FDA Label Image

Image (Rebif 07f)

FDA Label Image

Caution (Rebif 07g)

FDA Label Image

Image (Rebif 07h)

FDA Label Image

Image (Rebif 07i)

FDA Label Image

Image (Rebif 07j)

FDA Label Image

Image (Rebif 07k)

FDA Label Image

Principal Display Panel (Kit Carton-NDC 44087-8822-1)

The text describes a Titration Pack for the medication %?ebif‘E (interferon beta-1a) for subcutaneous injection. The pack includes six single-use prefilled syringes in two different strengths: 8.8 mcg/0.2 mL and 22 mcg/0.5 mL. A medication guide for patients is included. The National Drug Code (NDC) is 44087-8822-1. The last line appears to be non-English characters and cannot be evaluated.*

FDA Label Image

Principal Display Panel (Kit Carton-NDC 44087-0188-1)

This is a medication called "yArebif Rebidose" which is an injection containing interferon beta-1a. The Titration Pack comes in two dosages, 22mcg and 0.5mL. The medication is given through subcutaneous injection and comes with a Medication Guide that must be given to each patient. The package contains 6 single-use autoinjectors of 8.8 mcg / 0.2 mL and 6 single-use autoinjectors of 22 mcg / 0.5 mL. NDC code for this is 44087-0188-1. This medication requires a prescription from a healthcare professional.*

FDA Label Image

Principal Display Panel (12 Single Use Prefilled Syringe Carton-22 mcg/0.5 mL)

AReDif is a medication that contains interferon beta-1a and is administered via subcutaneous injection. The box contains 12 prefilled syringes, each with a capacity of 0.5 mL and a concentration of 22 meg. The medication is only available with a prescription and comes with a guide for patients. The NDC code for the product is 44087-0022-3.*

FDA Label Image

Principal Display Panel (12 Single Use Prefilled Syringe Carton-44 mcg/0.5 mL)

This is a medication containing interferon beta-1a, which is intended for subcutaneous injection. It comes in a package containing 12 single-use prefilled syringes and is available only by prescription. The enclosed medication guide is provided for patient information. The NDC number is 44087-0044-3.*

FDA Label Image

Principal Display Panel (12 Single Use Autoinjector Carton-22 mcg / 0.5 mL)

Arebif® Rebidose® is an injection of interferon beta-1a provided in 12 single-use autoinjectors with a volume of 0.5 mL and a concentration of 22 μg/0.5 mL. It is intended for subcutaneous injection. A medication guide is enclosed and must be given to each patient by the pharmacist.*

FDA Label Image

Principal Display Panel (12 Single Use Autoinjector Carton-44 mcg / 0.5 mL)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.